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INTRODUCTION 
 
Arterial stiffness, which increases with advancing age, is known to lead to cardiovascular disease. 
Pulse wave velocity (PWV), known as an indicator of arterial stiffness, is frequently assessed by 
determining carotid-femoral PWV (cfPWV) or brachial-ankle PWV (baPWV). Increased cfPWV and 
baPWV has been reported to be associated with increased risks of total or cardiovascular mortality 
in individuals with chronic conditions, as well as in community-dwelling individuals. In older 
individuals, it is important to predict not only mortality but also impairment in activities of daily 
living (ADL). In Japan, the major causes of impairment in ADL include cerebrovascular diseases, 
dementia, falls, fracture, and disuse syndrome. Arterial stiffness, as determined by cfPWV, has been 
reported to be associated with the incidence of stroke, prevalence of cognitive dysfunction and 
reduced thigh muscle mass. However, there are no reports regarding an association between 
baPWV and the onset of ADL impairment. The purpose of this study was therefore to evaluate the 
relationship between baPWV level and onset of ADL impairment during three-years among 
community-dwelling older individuals. 
 
METHODS 
 
Study Population 
The participants were elderly people who aged 65 years and over living in Kahoku, and 577 
individuals who did first time consultation of the medical examination in 2000 to 2003. Of the 577 
individuals, 127 were excluded from the present analysis for the following reasons: 18 had baPWV 
unmeasurable state, 80 had self-reported impairment in ADL items in the baseline questionnaire, 
15 had atrial fibrillation, 5 had medical history of arteriosclerosis obliterans (ASO), and 9 had an 
abnormal ankle/brachial pressure index (ABI) of less than 0.9. Therefore, the effective sample of 
this study included 450 participants (181 men and 269 women; mean ± SD of age at entry, 76.6 ± 5.7 
years). 
 
Brachial-Ankle Pulse Wave Velocity Measurements 
Measurements of baPWV and ABI were conducted automatically by a form PWV/ABI instrument 
(Colin Co., Ltd., Komaki, Japan). Each subject lay in a spine position for at least five minutes before 
having baPWV / ABI measurements. The measurements were performed twice consecutively and 
the mean of the two measurements was used. 
The participants were dichotomized according to a median value of baPWV and that of ABI.  
 
 
 
 
Follow-up Survey for Mortality and Onset of ADL impairment 
For participants who died during the follow-up, the date of death was obtained from the death 
certificate submitted to the municipality. For all participants, the performance of seven ADL items 
(walking, ascending stairs, eating, dressing, toilet, bathing, and grooming) was evaluated through 
the annual self-administered questionnaires at study entry and 12, 24, and 36 months. The seven 
ADL items were rated from 3 to 0 (3, needs no help‐0, totally dependent), and total score ranging 
from 0 to 21. A total of 450 participants with an ADL score ≥ 20 at study entry were included as the 
eligible subjects of this study. The participants who scored ≤19 at 12-, 24- or 36-month follow-up 
were defined as those who experienced the onset of ADL impairment. After excluding 28 
participants who died and 13 participants who had unknown ADL status during the follow-up, 409 
participants (160 men and 249 women; mean ± SD of age at entry, 76.4 ± 5.7 years) were used in the 
analyses regarding the association between baPWV levels and onset of ADL impairment. The 
incidence of medical conditions including cardiovascular disease(CVD) and fall/fracture were 
evaluated through the annual questionnaires. Participants who reported the onset of ADL 
impairment in a specific year were grouped according to whether self-reported occurrences of CVD 
and/or fall/fractures preceded or accompanied the onset of ADL impairment.  
 
Statistical Analysis 
A multiple logistic regression model was used to describe the association of baPWV levels 
dichotomized at the median value with mortality and onset of ADL impairment, while adjusting for 
age, sex, and blood pressure levels. The association between baPWV and onset of ADL impairment 
following/accompanying the occurrence of CVD and/or fall/fracture was analyzed. The odds ratio for 
the onset of ADL impairment following/accompanying respective conditions for comparing high vs. 
low baPWV was computed with excluding participants who experienced the onset of ADL 
impairment following/accompanying other conditions. 2-sided P values less than 0.05 were 
considered statistically significant. All analyses were performed using SPSS 18.0J for Windows 
(SPSS Japan Inc., Tokyo). 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
The median of baPWV was 18.61 m/sec for all participants. The participants with baPWV < 18.61 m 
/ sec (n=225) were grouped as the low baPWV, and the subjects with ≥ 18.61 m / sec (n=225) as the 
high baPWV. During three years of follow-up, 60 had an onset of ADL impairment. The high baPWV 
group had a higher proportion of participants who died (the high baPWV group vs. the low baPWV 
group, 9.3% vs. 3.1%) and a higher proportion of those who had an onset of ADL impairment (the 
high baPWV group vs. the low baPWV group, 20.7% vs. 9.3%). Multiple logistic regression models 
showed that a high baPWV level was significantly associated with an increased risk of mortality 
(adjusted odds ratio (OR) = 3.22, 95% confidence interval (CI) = 1.26–8.22), and with an increased 
risk for onset of ADL impairment (adjusted OR = 1.94, 95% CI = 1.03–3.63) after adjustment for age, 
sex, and systolic blood pressure (SBP). A high baPWV group had an increased risk for the onset of 
ADL impairment following/accompanying fall/fracture only (adjusted OR = 5.40, 95% CI = 1.11–
26.38). 
 
DISCUSSION 
In this study, the high baPWV group had a higher proportion of participants with the onset of ADL 
impairment following/accompanying fall/fracture as compared to the low baPWV group. It is 
therefore suggested that high baPWV levels reflect clinical conditions that present risks for 
falls/fractures. In older individuals, clinical conditions, such as sarcopenia and cognitive 
impairment, are risk factors for falls/fractures. The association between high baPWV and onset of 
ADL impairment is mediated by sarcopenia which is known to be related to weakened lower 
extremity performance and to be a risk factor for falls/fractures and functional disability. Previous 
studies have suggested that the mechanisms of sarcopenia are related to atherosclerosis. Cytokines, 
insulin-like growth factor (IGF)-I and androgens were reported to be involved in arterial stiffness. 
These may be pathophysiologic changes that underlie both of sarcopenia and arterial stiffness. 
Another possibility is that individuals with elevated baPWV are more likely to have silent cerebral 
small vessel diseases. The association between baPWV and ADL impairment is mediated by 
cerebral small vessel disease which elevates the prevalence of cognitive impairment and gait 
disturbances. 
In conclusion, the present study indicates that the assessment of arterial stiffness by baPWV 
contributes to identifying functionally independent community-dwelling older individuals at risk 
for ADL impairment, in particular ADL impairment associated with fall/fracture, as well as for 
mortality. 
 
